News

March 5, 2013

Activists fight FDA approval of genetically engineered salmon

Fishermen, environmentalists, food safety advocates and others are casting a wary eye on Washington, where the Food and Drug Administration is considering whether the Massachusetts-based company AquaBounty may sell genetically engineered salmon to consumers in the U.S. Among the worries is that the fish might escape and mix with wild salmon. The company says that’s unlikely, not only because the fish are sterile but also because of its production process.

Related content

Comments

Editor's Choice Videos